Demographics and clinical characteristics of 355 children with juvenile idiopathic arthritis.
| Values | |
|---|---|
| Age, yrs, mean (SD) | 13.5 (2.7) |
| Female sex | 241 (69.5)a |
| Self-reported race | |
| Asian | 7 (2) |
| Black | 9 (2.5) |
| White | 288 (81.1) |
| > 1 race | 13 (3.7) |
| Prefer not to answer | 28 (7.9) |
| Other | 10 (2.8) |
| Self-reported ethnicity | |
| Hispanic | 28 (7.9) |
| Non-Hispanic | 327 (92.1) |
| Insurance | |
| Private | 304 (85.6) |
| Government | 32 (9) |
| Other | 19 (5.4) |
| Parent highest level of education | |
| Less than college degree | 32 (9) |
| College degree or higher | 193 (54.4) |
| Prefer not to answer or missing | 130 (36.6) |
| Disease duration, mos, mean (SD, range) | 75.0 (47.7, 2.5-200.1) |
| Disease category | |
| Oligoarticular | 120 (33.8) |
| Polyarticularb | 130 (36.6) |
| Spondyloarthritisc | 89 (25.1) |
| Systemic | 16 (4.5) |
| Active disease | 122 (34.4) |
| No. of active joints, median (IQR, range) | 0 (0-1, 0-20) |
| cJADAS10, mean (SD, range) | 3.6 (4.7, 0-28) |
| Medications | |
| nbDMARDs | 307 (86.5) |
| Biologics | 260 (73.2) |
| Systemic CS | 13 (3.7) |
| NSAIDs | 208 (58.6) |
| Other | 183 (51.5) |
Values are n (%) unless otherwise indicated.
↵a n = 8 missing.
↵b Includes rheumatoid factor positive and negative.
↵c Includes enthesitis-related arthritis, psoriatic arthritis, and juvenile ankylosing spondylitis. cJADAS10: 10-joint clinical Juvenile Arthritis Disease Activity Score; CS: corticosteroid; DMARD: disease-modifying antirheumatic drug; nbDMARD: nonbiologic DMARD; NSAID: nonsteroidal antiinflammatory drug.